StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Last viewed:
eqrx
Prices are updated after-hours
Sector
Professional, Scientific, And Technical Services
1
Industry
Research And Development In Biotechnology
1
Name
Eqrx Inc
1
Symbol
Abos
1
Abvn
1
Acan
1
Acfn
1
Acxp
1
Adsv
1
Aghc
1
Akya
1
Alzn
1
Amady
1
Amam
1
Anro
1
Argq
1
Aura
1
Avbp
1
Avte
1
Bctx
1
Bimt
1
Biogy
1
Bixt
1
Blnc
1
Bmea
1
Bmtm
1
Bnoef
1
Bodi
1
Brns
1
Brrn
1
Brtx
1
Bssp
1
Buru
1
Bzyr
1
Cbus
1
Cdt
1
Cgon
1
Chmx
1
Cicn
1
Clcs
1
Cldi
1
Clts
1
Clvly
1
Cmpx
1
Cntb
1
Cnvy
1
Crdl
1
Crvo
1
Crxm
1
Ctagy
1
Ctcx
1
Cyn
1
Cyth
1
Dawn
1
Dcac
1
Dh
1
Dnax
1
Dnth
1
Docs
1
Domh
1
Dsgn
1
Ecox
1
Ednmy
1
Tags
Treatment
1
Venue
Nasdaq
1
Ipo Year
2021
1
Country
United States
1
Sec Forms
10-q
1
8-k
1
Effect
1
Sec Forms Date
2023 - 05 - 08
1
2023 - 03 - 13
1
2023 - 03 - 06
1
News In 15d
0
1
News In 30d
0
1
Created At
2022 - 01 - 01
1
Professional, Scientific, and Technical Services
Eqrx
EQRx Inc
EQRX
|
$2.34
2.14%
17M
|
Professional, Scientific, and T...
(
0.0%
1d)
(
0.0%
1m)
(
26.5%
1y)
(
0.0%
2d)
(
0.0%
3d)
(
0.0%
7d)
(
399.91%
volume)
Earnings Calendar: 2023-11-09
Market Cap: $ 1,141,209,064
https://www.eqrx.com
Sec Filling
|
Patents
| 240 employees
EQRX
(US) EQRx, Inc., a pharmaceutical company, engages in developing medicines primarily for the treatment of oncology and immune-inflammatory diseases in the United States.
treatment
add to watch list
Paper trade
email alert is off
Press-releases
Revolution Medicines and EQRx Stockholders Approve EQRx Acquisition
Published:
2023-11-08
(Crawled : 17:00)
- globenewswire.com
EQRX
|
$2.34
2.14%
17M
|
Professional, Scientific, and T...
|
-2.09%
|
O:
0.0%
H:
1.26%
C:
-2.09%
RVMD
S
|
$34.95
-2.46%
-2.52%
1.2M
|
Health Technology
|
62.49%
|
O:
0.37%
H:
1.07%
C:
-1.81%
acquisition
Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital
Published:
2023-08-01
(Crawled : 11:00)
- globenewswire.com
EQRX
|
$2.34
2.14%
17M
|
Professional, Scientific, and T...
|
37.24%
|
O:
20.23%
H:
8.29%
C:
-1.46%
RVMD
S
|
$34.95
-2.46%
-2.52%
1.2M
|
Health Technology
|
34.1%
|
O:
-5.18%
H:
29.93%
C:
27.58%
acquire
EQRx to Hold First Quarter 2023 Financial Results Conference Call on Monday, May 8, 2023
Published:
2023-04-27
(Crawled : 12:20)
- globenewswire.com
EQRX
|
$2.34
2.14%
17M
|
Professional, Scientific, and T...
|
39.29%
|
O:
0.0%
H:
1.79%
C:
-3.57%
conference
financial
results
EQRx Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Corporate Progress
Published:
2023-02-23
(Crawled : 12:20)
- globenewswire.com
EQRX
|
$2.34
2.14%
17M
|
Professional, Scientific, and T...
|
7.34%
|
O:
0.0%
H:
2.29%
C:
1.38%
year
financial
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
67%
33%
Top 10 Gainers
Last 48 Hours Insiders Buying
RXO
P
200000
|
$19.37
2.32%
0.0%
1M
|
n/a
|
23:00
RKT
P
380
|
$11.68
1.3%
0.17%
1.9M
|
Finance
|
22:30
HROW
P
29400
|
$10.43
-3.87%
-4.03%
680K
|
Health Technology
|
22:30
BCDA
P
2750
|
$0.377
-1.4%
97K
|
Health Technology
|
22:00
RMCF
|
$3.67
3.38%
3.27%
11K
|
Consumer Non-Durables
|
20:10
12 months watchlist earnings calendar